Synedica Glow Skin 112mg pen | Synedica

Synedica Glow Skin 112mg pen

Synedica Glow Skin 112mg pen is a multi-peptide research formulation listed by Synedica in its cosmetic research product category. Designed as an injection pen kit for research and development purposes, this product combines three peptide components in a single formulation. Its stated composition includes GHK-Cu, BPC-157, and TB-500, with a total listed content of 112mg.

For customers researching the Synedica Glow Skin 112mg pen, understanding its composition, product format, and intended research context is essential. The product name identifies both the Synedica brand and the formulation’s stated total content, making it easier to distinguish from other peptide blends with different ingredient ratios or strengths.

Although the product is associated with skin-related research, its name should not be interpreted as evidence that it delivers a particular cosmetic result. The effects, safety, and suitability of the combined formulation have not been established simply by listing its individual ingredients.

Synedica Glow Skin Pen

One of the main characteristics of the Synedica Glow Skin 112mg pen is its three-component composition. According to the manufacturer’s product listing, the formulation contains the following ingredients:

• GHK-Cu – 80mg: A copper-binding peptide studied in scientific research involving skin biology, cellular signalling, and extracellular matrix processes.
• BPC-157 – 16mg: A synthetic peptide investigated primarily in preclinical research exploring biological and tissue-related processes.
• TB-500 – 16mg: A peptide associated with research into cellular and tissue biology.

Together, these ingredients account for the stated 112mg total formulation content. This composition information is useful when comparing the Synedica Glow Skin 112mg pen with other research formulations. However, research involving an individual ingredient does not establish that the combined product produces the same effects or has an acceptable safety profile in humans.

Understanding the Role of GHK-Cu | Synedica Glow Skin

GHK-Cu is the largest component of the Synedica Glow Skin 112mg pen. It has attracted scientific interest because of its relationship with copper and several biological processes investigated in skin and extracellular matrix research.

Researchers have examined GHK-Cu in different experimental settings to better understand its biological properties. These areas of investigation help explain why copper-binding peptides appear in discussions about cosmetic science and skin biology.

Nevertheless, laboratory findings should not be confused with demonstrated clinical benefits. The presence of GHK-Cu in the Synedica Glow Skin 112mg pen does not establish that the finished formulation improves skin texture, increases collagen in humans, or reverses visible signs of ageing.

BPC-157 and TB-500 in the Formulation | Synedica UK

The Synedica Glow Skin 112mg pen also lists BPC-157 and TB-500 as components of its combined formulation. Both compounds have been discussed in experimental research, particularly in relation to biological processes involving cells and tissues.

BPC-157 has been investigated mainly in preclinical settings, while research associated with TB-500 examines aspects of peptide and cellular biology. These research backgrounds provide context for understanding the formulation’s ingredients without implying that the finished product has proven therapeutic or cosmetic effects.

Importantly, combining these substances does not automatically establish their compatibility, effectiveness, or safety. Reliable conclusions require appropriate evidence concerning the specific formulation, its quality, and its intended application.